176661-73-7Relevant articles and documents
INDOLE DERIVATIVES FOR THE TREATMENT OF BONE DISEASES
-
Page/Page column 84, (2010/02/12)
This invention relates to a method for preventing and/or treating bone diseases which comprises administering a potentiator of TGF-beta activity such as the compound of the formula [I] or pharmaceutically acceptable salts thereof to human being or animals
CARBODIIMIDE COUPLING REAGENT
-
, (2008/06/13)
The present invention relates to compounds used for increasing activation of the 5-HT1F receptor.
5-SUBSTITUTED-3-(1,2,3,6-TETRAHYDROPYRIDIN-4-YL)-AND 3-(PIPERIDIN-4-YL)-1H-INDOLES: NEW 5-HT1F AGONISTS
-
, (2008/06/13)
This invention provides novel 5-HT 1F agonists of Formula I STR1 where A--B, R, R 1 and X are as defined in the specification, which are useful for the treatment of migraine and associated disorders.
6-SUBSTITUTED-1,2,3,4-TETRAHYDRO-9H-CARBAZOLES AND 7-SUBSTITUTED-10H-CYCLOHEPTA [7,6-B]INDOLES: NEW 5-HT1F AGONISTS
-
, (2008/06/13)
This invention provides novel 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta[7,6-b]indoles. These compounds are 5-HT 1F agonists which are useful for the treatment of migraine and associated disorders.
Use of serotonin 5-HT1F agonists for the prevention of migraine
-
, (2008/06/13)
This invention provides methods for the prevention of migraine which comprises administering to a mammal in need thereof a serotonin 5-HT1F agonist.
3--4--and 3--4-piperidinyl-1h-indoles: new 5-HT1F agonists
-
, (2008/06/13)
This invention provides novel 5-HT1F agonists which are useful for the treatment of migraine and associated disorders having the following formula: STR1 wherein A, B, X, Y, Ar and n are defined in the specification.
5-HT1F agonists for the treatment of migraine
-
, (2008/06/13)
This invention provides novel 5-HT1F agonists which are useful for the treatment of migraine and associated disorders.